Cold Chain Packaging
US-2024300712-A1 · Sep 12, 2024 · US
US2017348192A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2017348192-A1 |
| Application number | US-201715687059-A |
| Country | US |
| Kind code | A1 |
| Filing date | Aug 25, 2017 |
| Priority date | Feb 28, 2012 |
| Publication date | Dec 7, 2017 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Coated pharmaceutical packages are disclosed. The coated pharmaceutical packages may include a glass body comprising a first surface and a second surface opposite the first surface. The glass body may be a glass container formed from a borosilicate glass composition and the first surface is an exterior surface of the glass container. A low-friction coating may be positioned on at least a portion of the first surface of the glass body. In embodiments, the low-friction coating may be a fluoropolymer.
Opening claim text (preview).
What is claimed is: 1 . A coated pharmaceutical package comprising: a glass body comprising a first surface and a second surface opposite the first surface, wherein the glass body is a glass container formed from a borosilicate glass composition and the first surface is an exterior surface of the glass container; and a low-friction coating positioned on at least a portion of the first surface of the glass body, the low-friction coating comprising a fluoropolymer. 2 . The coated pharmaceutical package of claim 1 , wherein the low-friction coating comprises: a coupling agent layer positioned on the first surface of the glass body; and a polymer layer positioned over the coupling agent layer, the polymer layer comprising the fluoropolymer. 3 . The coated pharmaceutical package of claim 1 , wherein the coupling agent layer comprises a silsesquioxane. 4 . The coated pharmaceutical package of claim 1 , wherein the low-friction coating has a coefficient of friction of less than or equal to 0.6. 5 . The coated pharmaceutical package of claim 1 , wherein a thickness of the low friction coating is less than or equal to 1 μm. 6 . The coated pharmaceutical package of claim 1 , wherein a thickness of the low friction coating is less than or equal to 100 nm. 7 . The coated pharmaceutical package of claim 1 , wherein the coated pharmaceutical package is thermally stable at a temperature of at least about 260° C. for 30 minutes. 8 . The coated pharmaceutical package of claim 1 , wherein a retained strength of the pharmaceutical package in horizontal compression does not decrease by more than about 20% after exposure to an elevated temperature of 260° C. for 30 minutes and abrasion under a 30 N load. 9 . The coated pharmaceutical package of claim 1 , wherein the portion of the exterior surface of the coated pharmaceutical package with the low-friction coating contains less than 6 glass checks per 5 mm length when abraded along a length of about 20 mm with a second coated borosilicate glass pharmaceutical package in a vial-on-vial testing jig under a normal load of 30 N and after exposing the coated glass pharmaceutical package and the second coated glass pharmaceutical package to a temperature of at least about 260° C. for 30 minutes. 10 . A coated pharmaceutical package comprising: a glass body comprising a first surface and a second surface opposite the first surface, wherein the glass body is a glass container formed from an alkali aluminosilicate glass having a Class HGA 1 hydrolytic resistance when tested according to the ISO 720-1985 testing standard and the first surface is an exterior surface of the glass container; and a low-friction coating positioned on at least a portion of the first surface of the glass body, the low-friction coating comprising a fluoropolymer. 11 . The coated pharmaceutical package of claim 10 , wherein the low-friction coating comprises: a coupling agent layer positioned on the first surface of the glass body; and a polymer layer positioned over the coupling agent layer, the polymer layer comprising the fluoropolymer. 12 . The coated pharmaceutical package of claim 11 , wherein the coupling agent layer comprises a silsesquioxane. 13 . The coated pharmaceutical package of claim 10 , wherein the low-friction coating has a coefficient of friction of less than or equal to 0.6. 14 . The coated pharmaceutical package of claim 10 , wherein a thickness of the low friction coating is less than or equal to 1 μm. 15 . The coated pharmaceutical package of claim 10 , wherein a thickness of the low friction coating is less than or equal to 100 nm. 16 . The coated pharmaceutical package of claim 10 , wherein the coated pharmaceutical package is thermally stable at a temperature of at least about 260° C. for 30 minutes. 17 . The coated pharmaceutical package of claim 10 , wherein a retained strength of the pharmaceutical package in horizontal compression does not decrease by more than about 20% after exposure to an elevated temperature of 260° C. for 30 minutes and abrasion under a 30 N load. 18 . The coated pharmaceutical package of claim 10 , wherein the portion of the exterior surface of the coated pharmaceutical package with the low-friction coating contains less than 6 glass checks per 5 mm length when abraded along a length of about 20 mm with a second coated borosilicate glass pharmaceutical package in a vial-on-vial testing jig under a normal load of 30 N and after exposing the coated glass pharmaceutical package and the second coated glass pharmaceutical package to a temperature of at least about 260° C. for 30 minutes. 19 . A coated pharmaceutical package comprising: a glass body comprising a first surface and a second surface opposite the first surface, wherein the glass body is a glass container formed from a borosilicate glass composition and the first surface is an exterior surface of the glass container; and a low-friction coating positioned on at least a portion of the first surface of the glass body, the low-friction coating comprising a silsesquioxane-based polymer. 20 . The coated pharmaceutical package of claim 19 , wherein the low-friction coating has a coefficient of friction of less than or equal to 0.6. 21 . The coated pharmaceutical package of claim 19 , wherein a thickness of the low friction coating is less than or equal to 1 μm. 22 . The coated pharmaceutical package of claim 19 , wherein a thickness of the low friction coating is less than or equal to 100 nm. 23 . The coated pharmaceutical package of claim 19 , wherein the coated pharmaceutical package is thermally stable at a temperature of at least about 260° C. for 30 minutes. 24 . The coated pharmaceutical package of claim 19 , wherein a retained strength of the pharmaceutical package in horizontal compression does not decrease by more than about 20% after exposure to an elevated temperature of 260° C. for 30 minutes and abrasion under a 30 N load. 25 . The coated pharmaceutical package of claim 19 , wherein the portion of the exterior surface of the coated pharmaceutical package with the low-friction coating contains less than 6 glass checks per 5 mm length when abraded along a length of about 20 mm with a second coated borosilicate glass pharmaceutical package in a vial-on-vial testing jig under a normal load of 30 N and after exposing the coated glass pharmaceutical package and the second coated glass pharmaceutical package to a temperature of at least about 260° C. for 30 minutes. 26 . A coated pharmaceutical package comprising: a glass body comprising a first surface and a second surface opposite the first surface, wherein the glass body is a glass container formed from an alkali aluminosilicate glass having a Class HGA 1 hydrolytic resistance when tested according to the ISO 720-1985 testing standard and the first surface is an exterior surface of the glass container; and a low-friction coating positioned on at least a portion of the first surface of the glass body, the low-friction coating comprising a silsesquioxane-based polymer. 27 . The coated pharmaceutical package of claim 26 , wherein the low-friction coating comprises: a coupling agent layer positioned on the first surface of the glass body; and a polymer layer positioned over the coupling agent layer, the polymer layer comprising the silsesquioxane-based polymer.
Details; Accessories therefor (A61J7/00 takes precedence; openers B65D, B67B7/00) · CPC title
Coverings or external coatings (wrappers B65D65/00) · CPC title
Details of other kinds or types of rigid or semi-rigid containers · CPC title
Coating the outside · CPC title
with silicon-containing compounds · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.